Navigation Links
Dragon Pharma Announces June 21, 2009 for 2009 Annual Shareholders' Meeting
Date:5/19/2009

VANCOUVER, May 19 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced that June 21, 2009 has been set as the date for the Annual Stockholders' Meeting.

The Annual Meeting of Dragon stockholders will be held at Hyatt Regency Hong Kong, Sha Tin, 18 Chak Cheung Street, Sha Tin, New Territories, Hong Kong, P.R. China at 10:30 am local time. Stockholders of record as of the close of business on May 19, 2009 will be entitled to vote on the election of directors.

On or about May 25, 2009, the Company will send to these stockholders a copy of the proxy statement in connection to the Annual Meeting.


'/>"/>
SOURCE Dragon Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Biologic Products to Present at CCG IRs China Rising Conference and Oppenheimers China Dragon Call Conference in New York
2. Dragon to Present at BioContact Quebec 2008
3. Dragon Pharma Announces Results of the Annual General Meeting
4. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
5. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
6. Dragon Pharma announces 2007 full year financial results
7. Dragon retains leading investor relations firm
8. Dragon announces new product launch; increase in annual production output capacity
9. Dragon Announces R&D Achievement in Biotech Manufacturing Process
10. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 30, 2015 According ... Market - Growth, Trends & Forecasts (2015-2020), , published by ... US$ 30.25 billion by the end of 2020, with ... accounting for more than 40% of the global market size. ... at a CAGR of 13.7% during the period of (2015-2020). ...
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation (NYSE: ... providers of post-acute healthcare services, offering both facility-based ... of operations for the second quarter ended June 30, ... characterized by strong volume growth in both segments ... said Jay Grinney, President and Chief Executive Officer ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... its GHS Label Guide . To align chemical container labeling with OSHA’s ... includes explanations of label components, an example of an accurate label, and pictogram ...
(Date:7/29/2015)... , July 29, 2015  Indivior PLC (LON: ... for naloxone nasal spray was accepted and received Priority ... for the treatment of opioid overdose. This naloxone nasal ... specially formulated for optimal absorption into the nasal mucosa. ... minimal training so individuals may be better equipped to ...
Breaking Biology Technology:Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27HealthSouth Reports Results for Second Quarter 2015 28HealthSouth Reports Results for Second Quarter 2015 29HealthSouth Reports Results for Second Quarter 2015 30HealthSouth Reports Results for Second Quarter 2015 31HealthSouth Reports Results for Second Quarter 2015 32HealthSouth Reports Results for Second Quarter 2015 33HealthSouth Reports Results for Second Quarter 2015 34
... Bulletin Board: TBIO) announces the following Webcast: , , What: ... Conference Call, ... Where: http://www.transgenomic.com/events.asp?id=6 , How: ... address above., ...
... 18 Despite the initial regulatory hiccups, the ... set to increase gradually. The patent expiry of ... opportunities, while driving the development of biosimilars. In ... to originator drugs due to their safety, efficacy ...
... the results today from a Stemedica-sponsored clinical study ... Professor Philippe Hernigou, MD, Ph.D. The clinical ... cells, allogeneic stem cells and comparative traditional treatment ... cells provided greater healing capability in a shorter ...
Cached Biology Technology:Reminder - Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast 2The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan 2The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan 3The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan 4Renowned Stem Cell Researcher Files Study Results With Stemedica 2Renowned Stem Cell Researcher Files Study Results With Stemedica 3
(Date:7/31/2015)... , July 31, 2015 The 10 th ... held by BGI from October 22-25, 2015, in Shenzhen ... The conference is celebrating its 10 th anniversary this year. ... the world,s most influential annual meetings in the ,omics, fields, ... scientific gatherings. ICG-10 focuses on recent breakthroughs ...
(Date:7/23/2015)... July 23, 2015 Research and Markets ... the "Global Outlook of the Biometrics Industry ... The global biometrics market is likely ... commercial applications owing to the uptake of multiple ... transformation that enhances the growth of biometrics in ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... In choosing a mate both males and females rely ... supply the best genes, best nesting site, best territory, ... Central,s open access journal Frontiers in Zoology ... parental behavior is determined by female ornamentation (ultraviolet coloration ...
... MADISON -- The blood-brain barrier -- the filter that governs ... brain -- is a marvel of nature. It effectively separates ... it keeps out bacteria, viruses and other agents that could ... disease, stroke and multiple sclerosis, for example, and also is ...
... to give a comprehensive projection for this long perspective, based ... as on scenarios for future greenhouse-gas emissions. "Sea-level ... climate change," says Michiel Schaeffer of Climate Analytics and Wageningen ... time it takes for the world,s ice and water masses ...
Cached Biology News:Better looking birds have more help at home with their chicks 2Blood-brain barrier building blocks forged from human stem cells 2Blood-brain barrier building blocks forged from human stem cells 3Significant sea-level rise in a 2-degree warming world 2
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
Reported to support murine B lymphocytes, hematopoietic tissue from bone marrow, B cells stimulated with lipopolysaccharide, T lymphocytes, and a variety of hybrid cells....
... Modification of Ham's F-12 was developed for ... viral fusion. The modification consists of doubling ... ascorbic acid. The salt concentrations have been ... mg zinc sulfate per liter, which may ...
... isotonic, balanced salt solution. It is routinely used ... of whole blood at refrigerator temperatures for approximately ... blood is collected into a container of this ... is placed in a refrigerator at 2-8 C ...
Biology Products: